Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Xeroderma pigmentosum group C

MONDO:0010211

An autosomal recessive inherited disorder caused by mutations in the XPC gene. This disease is characterized by increased sensitivity to sunlight with the development of carcinomas at an early age and is caused by a defect in nucleotide excision repair.

Also known as: XP-C, XP3, XPC, XPCC, xeroderma pigmentosum group C, xeroderma pigmentosum group type C, xeroderma pigmentosum, complementation group type C, xeroderma pigmentosum, group C

3 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Metabolic disease (233) Hereditary disease (176) Skin disorder (132) Inborn errors of metabolism (45) Human disease (14) DNA repair disease (13) Hereditary skin disorder (6) Xeroderma pigmentosum (4) Disease of genetic or genomic mechanism (2)
Trials to join now! 1 Not yet finished but already full! 1 Completed 1
Sort by
  • New combo therapy targets cancer's DNA repair weakness

    Disease control Ongoing

    This study tests a combination of two drugs, avelumab and M6620, in people with advanced solid tumors that have spread or can't be removed by surgery. The tumors must have a specific DNA repair defect. The goal is to find the safest dose and see if the combination can help contro…

    Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

    Last updated Jun 27, 2026 13:07 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space